Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Bryan Rea"'
Autor:
Aseel Alsouqi, Jeffrey Kleinberger, Taylor S Werner, Rashid Awan, Saurav Chopra, Bryan Rea, Nidhi Aggarwal, Svetlana A. Yatsenko, Rafic Farah, Nathanael G. Bailey
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/09a388c1d05c4224908f33e18b9c59a8
Autor:
Wang, Sa A 1, Tam, Wayne 2, Tsai, Albert G 3, Arber, Daniel A 3, Hasserjian, Robert P 4, Geyer, Julia T 2, George, Tracy I 5, Czuchlewski, David R 5, Foucar, Kathryn 5, Rogers, Heesun J 6, Hsi, Eric D 6, Bryan Rea, B 7, Bagg, Adam 7, Dal Cin, Paola 8, Zhao, Chong 1, Kelley, Todd W 9, Verstovsek, Srdan 10, Bueso-Ramos, Carlos 1, Orazi, Attilio 2
Publikováno v:
In Modern Pathology August 2016 29(8):854-864
Autor:
Bryan Rea, Yen-Chun Liu, Alanna Maguire, Lorinda A. Soma, Chris M. Bacon, Michael G. Bayerl, Molly H. Smith, Michael T. Barrett, Steven H. Swerdlow, Sarah E. Gibson
Publikováno v:
Modern Pathology. 35:938-945
Autor:
Yen-Chun Liu, Gwendolyn M. Illar, Raniah Al Amri, Briana C. Canady, Bryan Rea, Svetlana A. Yatsenko, Julia T. Geyer
Publikováno v:
Modern Pathology. 35:625-631
Autor:
Gwendolyn M Illar, Nidhi Aggarwal, Eric D Carlsen, Yen-Chun Liu, Nathanael G. Bailey, Svetlana A. Yatsenko, Bryan Rea, Matthew Wild
Publikováno v:
American Journal of Clinical Pathology. 155:446-454
Objectives Hypocellular acute myeloid leukemia (AML) is uncommon. Despite the prognostic and therapeutic importance of mutational analysis, the mutational landscape of hypocellular AML is not well understood. Methods We identified 25 patients with hy
Publikováno v:
Arthritis & Rheumatology. 72:1154-1159
OBJECTIVE Distinguishing aortitis-induced aneurysms from noninflammatory aortic aneurysms is difficult and often incidentally diagnosed on histologic examination after surgical repair. This study was undertaken to examine surgically diagnosed aortiti
Publikováno v:
Modern Pathology. 33:566-575
Myelodysplastic syndrome with isolated del(5q) is a well-recognized entity with a relatively favorable prognosis. Isolated del(5q) in acute myeloid leukemia is rare and acute myeloid leukemia cases with isolated del(5q) are not well characterized. De
Autor:
Bryan, Rea, Yen-Chun, Liu, Alanna, Maguire, Lorinda A, Soma, Chris M, Bacon, Michael G, Bayerl, Molly H, Smith, Michael T, Barrett, Steven H, Swerdlow, Sarah E, Gibson
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 35(7)
Epstein-Barr virus (EBV)-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT lymphomas) were initially described in solid organ transplant recipients, and, more recently, in other immunodeficiency settings. The over
Autor:
Alexander E. Perl, Martin Carroll, Bryan Rea, Jonathan Canaani, Christopher D. Watt, Jennifer J.D. Morrissette, Julianne Qualtieri, Rachel L. Sargent, Christine M. McMahon
Publikováno v:
Blood Advances. 3:1581-1585
Key Points Gilteritinib induces 2 distinct marrow responses in FLT3-mutated AML: responses with and without differentiation. Ongoing clonal hematopoiesis is ubiquitous during gilteritinib therapy and may promote genetic evolution and drug resistance.
Autor:
Yen-Chun, Liu, Gwendolyn M, Illar, Raniah, Al Amri, Briana C, Canady, Bryan, Rea, Svetlana A, Yatsenko, Julia T, Geyer
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 35(5)
Therapy-related myeloid neoplasm (t-MN) arising in patients with prior cytotoxic treatments is considered a distinct entity due to its unfavorable prognosis. Latencies between the initial cytotoxic therapy and the occurrence of t-MNs vary but usually